newcastl
diseas
viru
ndv
member
paramyxovirina
subfamili
infect
speci
bird
great
threat
poultri
industri
around
world
report
success
produc
infecti
pseudotyp
e
hivluc
virus
hn
f
envelop
protein
ndv
investig
reveal
cytoplasm
domain
hn
f
especi
hn
play
signific
role
infect
effici
pseudotyp
hivluc
virus
replac
direct
fusion
cytoplasm
domain
hn
protein
vesicular
stomat
viru
g
vsvg
could
greatli
enhanc
destroy
infect
potenti
hn
fpseudotyp
ndvpseudotyp
hivluc
viru
establish
novel
neutral
assay
evalu
neutral
antibodi
ndv
ndvpseudotyp
hivluc
virus
compar
neutral
data
indic
result
determin
use
ndvpseudotyp
hivluc
virus
reliabl
convent
virusneutr
assay
vn
test
nativ
ndv
moreov
result
show
novel
neutral
assay
sensit
vn
test
newcastl
diseas
viru
ndv
belong
paramyxovirida
famili
found
worldwid
sinc
first
report
among
poultri
area
java
indonesia
england
viru
extens
rang
suscept
host
order
bird
report
capabl
infect
ndv
make
newcastl
diseas
nd
global
anim
health
concern
although
vaccin
chicken
perform
throughout
world
diseas
still
remain
endem
poultri
mani
region
accord
sever
diseas
chicken
isol
ndv
categor
three
pathotyp
lentogen
avirul
mesogen
intermedi
virul
velogen
highli
virul
strain
infect
velogen
strain
devast
effect
poultri
industri
due
high
rate
morbid
mortal
thu
virul
ndv
isol
notifi
offic
intern
epizoot
oie
obligatori
control
measur
upon
occurr
outbreak
diseas
genom
ndv
nonseg
singlestrand
negativesens
rna
encod
six
viral
protein
six
gene
nucleocapsid
np
phosphoprotein
p
matrix
fusion
f
hemagglutininneuraminidas
hn
larg
rnadepend
rna
polymeras
l
protein
two
addit
protein
v
w
produc
rna
edit
p
gene
transcript
hn
f
membran
protein
ndv
respons
mediat
ndv
infect
hn
mediat
viral
attach
sialic
acid
receptor
cell
f
protein
direct
membran
fusion
viru
cell
antibodi
hn
f
shown
abil
block
receptor
bind
viruscel
fusion
respect
therebi
protect
bird
virul
ndv
infect
elicit
neutral
antibodi
therefor
consid
high
prioriti
vaccin
design
moreov
effect
assay
evalu
neutral
antibodi
necessari
assess
viral
infect
vaccin
efficaci
present
haemagglutin
inhibit
hi
virusneutr
vn
assay
avail
detect
neutral
antibodi
ndv
hi
assay
abl
measur
neutral
antibodi
receptorbind
site
limit
term
low
sensit
high
incid
falseposit
convent
use
vn
assay
laborintens
timeconsum
requir
minimum
day
less
object
make
unsuit
larg
scale
evalu
neutral
antibodi
pseudovirusbas
neutral
assay
howev
proven
rapid
sensit
specif
highthroughput
system
evalu
neutral
antibodi
antivir
drug
discoveri
pseudoviru
backbon
commonli
lentivir
retrovir
vector
gener
carri
report
gene
luciferas
neutral
abil
antibodi
easili
quantifi
pseudotyp
viral
particl
heterolog
viral
glycoprotein
describ
sever
virus
includ
influenza
viru
sar
coronaviru
sendai
viru
hepat
c
viru
howev
pseudotyp
virus
ndv
envelop
glycoprotein
hn
f
yet
report
report
success
product
hn
fpseudotyp
ndvpseudotyp
hivluc
viral
particl
factor
impact
infect
effici
ndvpseudovirus
establish
novel
neutral
assay
ndvpseudotyp
hivluc
virus
evalu
neutral
antibodi
ndv
cell
line
viru
monoclon
antibodi
cell
use
infect
cultur
dulbecco
modifi
eagl
medium
dmem
supplement
heatinactiv
fetal
bovin
serum
fb
hyclon
humidifi
incub
atmospher
co
genotyp
vii
ndv
strain
isol
lab
propag
allanto
caviti
old
specif
pathogen
free
spf
embryon
chicken
egg
kept
rna
extract
neutral
assay
monoclon
antibodi
mab
hn
f
kind
gift
dr
shunlin
hu
univers
yang
zhou
total
rna
extract
ndv
use
commerci
rna
extract
kit
qiagen
use
cdna
product
random
primer
wildtyp
hn
f
amplifi
cdna
templat
primer
pair
hnu
atcagaattcatggaccgcgcggttaacag
hnl
cggctcgagttaaactctatcatccttg
fu
gatgtaagcttgtaatgggctccaaaccttctacc
fl
gatgttctagatcatgctcttgcagtggctctcat
respect
pcr
product
insert
pcagg
vector
ecor
ixho
hind
iii
xba
site
gener
pcaggshn
pcaggsf
respect
mutant
hn
f
construct
follow
strategi
vcthn
fvct
gener
replac
cytoplasm
domain
hn
f
cytoplasm
domain
vsvg
vct
vcthn
construct
directli
fuse
vct
start
codon
atg
nterminu
nterminu
hn
fdct
mutant
construct
delet
cytoplasm
domain
f
wildtyp
mutant
hn
f
insert
pcagg
facilit
express
cell
cell
express
wildtyp
mutant
hn
f
protein
ndv
resuspend
phosphat
buffer
salin
pb
cell
ml
pb
stain
monoclon
antibodi
hn
f
min
room
temperatur
unbound
antibodi
remov
wash
three
time
cell
label
fitcconjug
rabbit
antimous
igg
second
antibodi
invitrogen
min
wash
previous
describ
final
fix
polyformaldehyd
data
collect
cell
fac
analyz
use
flowjo
softwar
product
hivluc
viral
particl
pseudotyp
ndv
envelop
protein
vsvg
perform
previous
describ
briefli
cell
cm
diamet
dish
transfect
variou
combin
wildtyp
mutant
hn
f
plu
lentivir
vector
hivluc
mg
use
hitran
transfect
reagent
jpson
bioscienc
supernat
cultur
cell
replac
fresh
medium
h
post
transfect
rule
influenc
exist
complex
plasmidtransfect
reagent
follow
pseudoviru
infect
incub
h
supernat
transfect
cell
contain
pseudotyp
virus
harvest
filter
mm
syring
filter
pseudotyp
virus
use
infect
cell
immedi
frozen
requir
pseudotyp
virus
purifi
ultracentrifug
rpm
rotor
beckman
sucros
cushion
h
pellet
resuspend
pb
aliquot
storag
pseudotyp
virus
produc
describ
titrat
use
antigen
captur
assay
keybio
elisa
assay
perform
previous
describ
briefli
purifi
pseudotyp
virus
immobil
elisa
plate
thermo
fisher
scientif
ml
carbonatebicarbon
ph
overnight
incub
plate
wash
four
time
pb
contain
tween
pbst
block
skim
milk
pbst
h
plate
wash
first
detect
monoclon
antibodi
ad
well
incub
h
plate
wash
four
time
pbst
addit
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
invitrogen
well
incub
h
plate
wash
ml
tmb
substrat
ad
well
reaction
stop
use
n
h
incub
room
temperatur
min
od
valu
well
immedi
read
micropl
photomet
biotek
titrat
ndv
ndvpseudotyp
hivluc
viru
tissu
cultur
infecti
dose
tcid
assay
ndv
titrat
previous
describ
minim
modif
brief
cell
seed
plate
cell
per
well
h
viru
sampl
tenfold
serial
dilut
dmem
contain
fb
cell
infect
ml
dilut
viru
sampl
incub
day
cytopathogen
effect
cpe
cell
well
observ
use
light
microscopi
tcid
valu
calcul
method
titrat
ndvpseudotyp
hivluc
virus
perform
similarli
briefli
cell
seed
plate
cell
per
well
infect
tenfold
serial
dilut
ndvpseudotyp
hivluc
virus
pseudotyp
viru
infect
detect
measur
luciferas
activ
cell
h
post
infect
tcid
valu
calcul
method
immun
sera
ndv
field
sera
heatinactiv
min
twofold
serial
dilut
mix
tcid
ndvpseudotyp
hivluc
virus
incub
h
room
temperatur
pseudotypedvirusserum
mixtur
transfer
cell
preplat
plate
cellswel
well
per
dilut
incub
atmospher
co
h
luciferas
activ
cell
detect
describ
background
luminesc
produc
cellonli
control
pseudotyp
viru
posit
luminesc
produc
neg
serum
control
neg
serum
plu
pseudotyp
virus
includ
neutral
effici
calcul
follow
formula
luciferas
activ
experiment
wellluciferas
activ
cellonli
control
luciferas
activ
neg
serum
control
luciferas
activ
cellonli
control
serum
dilut
inhibit
calcul
use
graphpad
prism
version
softwar
set
neutral
titer
nt
titer
previous
describ
convent
neutral
assay
perform
cell
previous
describ
briefli
heatinactiv
sera
twofold
serial
dilut
incub
equal
volum
ndv
ml
contain
tcid
h
serumndv
mixtur
ad
cell
monolay
plate
well
per
dilut
day
incub
neutral
determin
cpe
observ
highest
dilut
serum
infect
inhibit
well
set
nt
titer
previous
describ
statist
analys
perform
use
pair
onetail
student
test
previous
describ
p
valu
less
consid
statist
signific
result
present
mean
valu
standard
deviat
sd
least
three
independ
experi
research
construct
six
recombin
plasmid
carri
wildtyp
f
f
fdct
cytoplasm
domain
f
protein
amino
residu
delet
fvct
cytoplasm
domain
f
protein
replac
vct
amino
residu
vsvg
wildtyp
hn
hn
vcthn
cytoplasm
domain
hn
amino
residu
replac
vct
vcthn
vct
directli
fuse
hn
nterminu
respect
figur
b
express
wildtyp
mutant
hn
f
protein
confirm
transfect
individu
recombin
plasmid
cell
follow
fac
analysi
h
later
shown
figur
hn
f
protein
recombin
plasmid
highli
express
cell
hivluc
base
lentivir
vector
bear
luciferas
report
gene
use
extens
product
pseudotyp
virus
determin
whether
hn
f
protein
ndv
could
incorpor
pseudotyp
hivluc
viral
particl
cotransfect
cell
hivluc
vector
pseudotyp
virus
supernat
purifi
use
ultracentrifug
incorpor
hn
f
determin
elisa
assay
shown
figur
b
probe
antihn
f
mab
show
significantli
higher
od
valu
well
coat
ndvpseudotyp
hivluc
virus
either
control
vsvgpseudotyp
viral
particl
result
indic
success
incorpor
hn
f
pseudotyp
viral
particl
next
look
address
whether
ndvpseudotyp
virus
infecti
cell
shown
figur
luciferas
activ
cell
infect
ndvpseudotyp
hivluc
virus
reach
rlu
much
higher
control
indic
success
product
infecti
ndvpseudotyp
hivluc
viru
although
ndvpseudotyp
hivluc
viral
particl
success
produc
infect
effici
found
lower
vsvgpseudotyp
hivluc
viru
figur
hypothes
may
due
impact
cytoplasm
domain
envelop
protein
address
four
plasmid
contain
mutant
hn
f
construct
figur
figur
altogeth
result
indic
cytoplasm
domain
hn
domin
factor
behind
infect
effici
ndvpseudotyp
hivluc
viru
vcthn
plu
f
fvct
optim
recombin
product
highli
infecti
pseudovirus
determin
feasibl
measur
neutral
antibodi
ndv
use
ndvpseudotyp
hivluc
viru
three
immun
sera
ndv
twofold
serial
dilut
incub
equal
volum
vcthn
fvctpseudotyp
hivluc
virus
contain
tcid
h
room
temperatur
serum
pseudoviru
mixtur
use
infect
cell
plate
h
shown
figur
luciferas
activ
increas
along
serum
dilut
figur
accordingli
neutral
effici
calcul
base
rlu
luciferas
activ
correspond
neg
serum
dilut
figur
dosedepend
correl
neutral
effici
serum
dilut
result
confirm
success
use
ndvpseudotyp
hivluc
virusbas
system
measur
neutral
antibodi
ndv
valid
neutral
assay
ndvpseudotyp
hivluc
virus
compar
nt
titer
determin
ndvpseudotyp
hivluc
virusbas
neutral
assay
measur
refer
neutral
assay
vn
test
shown
figur
nt
titer
sixteen
immun
sera
ndv
success
detect
neutral
assay
moreov
nt
titer
determin
ndvpseudotyp
hivluc
virusbas
neutral
assay
two
five
fold
higher
obtain
convent
vn
test
rang
respect
figur
strong
correl
two
neutral
assay
r
show
ndvpseudotyp
hivluc
virusbas
neutral
assay
reliabl
convent
vn
test
figur
perform
neutral
assay
ndvpseudotyp
hivluc
viru
convent
vn
test
sixteen
field
sera
posit
ndv
antigen
elisa
assay
data
shown
shown
tabl
neutral
antibodi
success
detect
sixteen
sera
use
ndvpseudotyp
hivluc
viru
versu
twelv
vn
test
result
indic
ndvpseudotyp
hivluc
virusbas
neutral
assay
sensit
convent
vn
test
pseudotyp
provid
abil
introduc
protein
differ
sourc
viral
vector
shell
mani
pseudotyp
vector
develop
use
retrovirus
lentivirus
momulv
vector
moloney
murin
leukemia
viru
vector
viru
given
compon
essenti
viral
replic
persist
infect
delet
genom
pseudotyp
virus
take
singlecycl
infect
thu
safe
altern
use
research
lab
extrem
virul
virus
far
pseudovirus
use
identif
viru
receptor
screen
evalu
neutral
antibodi
transduct
gene
target
cell
explor
mechan
viru
infect
previous
envelop
protein
sendai
viru
member
paramyxoviru
report
success
pseudotyp
lentiviru
vector
deriv
simian
immunodefici
viru
recent
two
paramyxoviru
pseudotyp
lentivir
vector
success
report
establish
abil
paramyxovirus
form
success
pseudovirus
success
produc
pseudotyp
hivluc
viru
particl
hn
f
protein
ndv
figur
first
report
ndvpseudotyp
retrovir
vector
add
list
paramyxoviru
pseudotyp
lentivri
vector
previou
report
shown
interact
matrix
protein
cytoplasm
domain
envelop
protein
requir
incorpor
envelop
protein
matur
viral
particl
inde
saw
lower
infect
effici
ndvpseudotyp
hivluc
viru
compar
vsvg
pseudotyp
hivluc
viru
figur
associ
lessoptim
interact
matrix
cytoplasm
domain
ndv
envelop
protein
paramyxovirus
two
envelop
protein
hn
f
given
delet
cytoplasm
domain
f
obstruct
pseudovir
packag
figur
specul
interact
f
matrix
protein
play
nonessenti
role
packag
ndvpseudotyp
hivluc
viru
suggest
interact
f
hn
suffici
f
incorpor
viron
howev
although
abl
success
produc
panel
function
ndv
pseudotyp
hivluc
virus
figur
found
would
lose
infect
use
immedi
pseudotyp
virus
hn
plu
fdct
hn
plu
fvct
data
shown
cytoplasm
domain
hn
replac
optim
one
vct
stabil
ndvpseudoviru
substanti
improv
remain
stabl
even
repeat
thaw
phenomena
perhap
indic
interact
matrix
protein
cytoplasm
domain
hn
f
especi
hn
protein
correl
stabil
ndvpseudotyp
hivluc
viru
also
found
replac
cytoplasm
domain
hn
vct
enhanc
infect
effici
stabil
ndvpseudotyp
hivluc
viru
infect
lost
vct
ad
directli
nterminu
hn
protein
regardless
combin
f
protein
use
figur
result
differ
seen
previou
research
sendai
viru
similar
replac
fusion
carri
result
suggest
among
paramyxovirus
character
packag
lentivir
vector
may
differ
paramyxovirus
receptor
bind
hemagglutininneurominidas
activ
ha
site
resid
region
hn
therefor
hi
assay
sometim
use
evalu
neutral
antibodi
recogn
receptorbing
site
ndv
bind
receptor
cell
conform
chang
envelop
protein
take
place
research
neutral
antibodi
shown
numer
antibodi
recogn
region
outsid
receptorbind
site
abl
neutral
viru
infect
neutral
antibodi
hi
assay
would
inadequ
commonli
neutral
antibodi
ndv
evalu
vn
test
nativ
ndv
howev
vn
test
nativ
ndv
timeconsum
requir
least
day
lessobject
studi
develop
novel
assay
evalu
neutral
antibodi
use
ndvpseudotyp
hivluc
viru
figur
assay
capabl
evalu
neutral
activ
antibodi
detect
viral
entranc
host
cell
compar
current
avail
vn
test
ndvpseudotyp
hivluc
virusbas
assay
requir
two
day
easili
perform
larg
scale
luminomet
result
show
nt
titer
determin
ndvpseudotyp
hivluc
virusbas
assay
around
time
higher
convent
vn
test
figur
reflect
greater
sensit
detect
nt
titer
use
establish
luciferasebas
assay
compar
perform
microscop
observ
cpe
use
vn
assay
sensit
pseudovirusbas
assay
confirm
detect
neutral
antibodi
tabl
two
neg
sera
determin
convent
vn
test
obviou
advantag
highthroughput
rapid
sensit
reproduc
less
subject
system
encourag
develop
mani
pseudotyp
lentiviru
establish
neutral
assay
equin
influenza
nipah
viru
chikungunya
viru
coxsackieviru
novel
neutral
assay
two
method
titrat
ndvpseudotyp
hivluc
virus
one
measur
luciferas
activ
pseudoviru
infect
tcid
assay
result
show
titrat
measur
luciferas
activ
easili
perform
howev
valu
titrat
method
variabl
less
object
compar
tcid
assay
prefer
latter
method
titrat
ndvpseudotyp
hivluc
virus
summari
studi
report
success
product
hivluc
virus
pseudotyp
envelop
protein
ndv
analyz
factor
affect
infect
effici
ndvpseudotyp
hivluc
virus
optim
plasmid
combin
produc
highli
infecti
pseudotyp
virus
moreov
neutral
assay
use
ndvpseudotyp
hivluc
virus
success
develop
evalu
neutral
antibodi
ndv
